Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;14(3):721-30.
doi: 10.1007/s10461-009-9559-5. Epub 2009 Apr 16.

Community-based DOT-HAART accompaniment in an urban resource-poor setting

Maribel Muñoz  1 , Karen Finnegan, Jhon Zeladita, Adolfo Caldas, Eduardo Sanchez, Miriam Callacna, Christian Rojas, Jorge Arevalo, Jose Luis Sebastian, Cesar Bonilla, Jaime Bayona, Sonya Shin
Affiliations

Community-based DOT-HAART accompaniment in an urban resource-poor setting

Maribel Muñoz et al. AIDS Behav. 2010 Jun.

Abstract

From December 2005 to April 2007, we enrolled 60 adults starting antiretroviral therapy (ART) in a health district of Lima, Peru to receive community-based accompaniment with supervised antiretroviral (CASA). Paid community health workers performed twice-daily home visits to directly observe ART and offered additional medical, social and economic support to CASA participants. We matched 60 controls from a neighboring district by age, CD4 and primary referral criteria (TB status, female, neither). Using validated instruments at baseline and 12 months (time of DOT-HAART completion) we measured depression, social support, quality of life, HIV-related stigma and self-efficacy. We compared 12 month clinical and psychosocial outcomes among CASA versus control groups. CASA participants experienced better clinical and psychosocial outcomes at 12 months, including proportion with virologic suppression, increase in social support and reduction in HIV-associated stigma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Description and time-line of community-based intervention
Fig. 2
Fig. 2
Intervention and control group flowchart
See this image and copyright information in PMC

References

    1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England), 14(4), 357–366. doi:10.1097/00002030-200003100-00008. - DOI - PubMed
    1. Behforouz HL, Kalmus A, Scherz CS, Kahn JS, Kadakia MB, & Farmer PE (2004). Directly observed therapy for HIV antiretroviral therapy in an urban US setting. Journal of Acquired Immune Deficiency Syndromes, 36(1), 642–645. doi: 10.1097/00126334-200405010-00016. - DOI - PubMed
    1. Berger BE, Ferrans CE, & Lashley FR (2001). Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in Nursing & Health, 24(6), 518–529. doi:10.1002/nur.10011. - DOI - PubMed
    1. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, et al. (2008). Overestimates of survival after HAART: Implications for global scale-up efforts. PLoS ONE, 3(3), e1725. - PMC - PubMed
    1. Bradley-Ewing A, Thomson D, Pinkston M, & Goggin KJ (2008). A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence. AIDS Patient Care and STDs, 22(8), 663–668. doi:10.1089/apc.2007.0190. - DOI - PMC - PubMed

Publication types